Volker Knappertz
Direktor/Vorstandsmitglied bei Sutura Therapeutics Ltd.
Vermögen: 299 455 $ am 31.05.2024
Profil
Volker Knappertz bekleidet die Position des Chief Medical Officer bei GW Pharmaceuticals Plc. Zuvor war Dr. Knappertz als Vice President-Clinical Development bei Teva Pharmaceuticals Ltd. tätig. Dr. Knappertz promovierte an der Universitt zu Kln.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.03.2024 | 55 250 ( 0,04% ) | 299 455 $ | 31.05.2024 |
Aktive Positionen von Volker Knappertz
| Unternehmen | Position | Beginn |
|---|---|---|
Sutura Therapeutics Ltd.
 Sutura Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Sutura Therapeutics Ltd. is a British biopharmaceutical company that is advancing biomolecular medicine through its Peptigo technology platform. The company is based in Macclesfield, UK. Sutura's team is made up of skilled and passionate professionals who bring a unique perspective to the table. The company was founded in 2020, and Edwin J. Wagena has been the CEO of the company since 2021. | Direktor/Vorstandsmitglied | 01.09.2021 |
Ehemalige bekannte Positionen von Volker Knappertz
| Unternehmen | Position | Ende |
|---|---|---|
| GW PHARMACEUTICALS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 |
Teva Pharmaceuticals Ltd.
 Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was incorporated on October 19, 1972 and is headquartered in Castleford, the United Kingdom. | Corporate Officer/Principal | 01.05.2017 |
| AURINIA PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Volker Knappertz
| Universität zu Köln | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
GW Pharmaceuticals Ltd.
 GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology GW Pharmaceuticals Ltd. operates as an intermediate holding company and management company for investments in its subsidiaries. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Teva Pharmaceuticals Ltd.
Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was incorporated on October 19, 1972 and is headquartered in Castleford, the United Kingdom. | Health Technology |
Sutura Therapeutics Ltd.
Sutura Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Sutura Therapeutics Ltd. is a British biopharmaceutical company that is advancing biomolecular medicine through its Peptigo technology platform. The company is based in Macclesfield, UK. Sutura's team is made up of skilled and passionate professionals who bring a unique perspective to the table. The company was founded in 2020, and Edwin J. Wagena has been the CEO of the company since 2021. | Commercial Services |
